Use of mutated VEGF for antiangiogenic therapy
The invention relates to the application of oligonucleotide and polypeptide sequences of molecules belonging to the vascular permeability factor (VPF) family, their receptors and co-receptors and to their modifications in active immunotherapy against pathological entities whose course is associated...
Saved in:
Main Authors | , , , , , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
08.06.2011
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!